Idiopathic Increased Femoral Anteversion Clinical Trial
— FDROfficial title:
Derotational Femoral Osteotomy With Either Percutaneous Osteotomy and Intramedullary Nailing or Open Approach and Plating - a Randomized Controlled Trail
Femoral derotational osteotomy is the gold standard to correct symptomatic patients with increased femoral AV. There is no clear evidence in the literature supporting which surgical technique or implant that should be used. Traditionally these patients are treated with an open osteotomy and plate and screw fixation. In recent years intramedullary nailing with adolescent interlocking nail has been described and has shown to be a safe method. Percutaneous osteotomy and intramedullary nailing is considered a less invasive technique compared with open osteotomy and plate and screw fixation. The primary objective of this project, is to investigate if derotational osteotomy by means of percutaneous osteotomy and nailing is a safe and accurate method compared to an open approach and plating.
| Status | Recruiting |
| Enrollment | 42 |
| Est. completion date | June 15, 2031 |
| Est. primary completion date | June 15, 2025 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 10 Years to 18 Years |
| Eligibility | Inclusion Criteria: - Radiographic findings: Femoral AV angle = 30° - Age 10-18 years. - Hip or/and knee pain - Less than 15 degrees external rotation of the hips Exclusion Criteria: - Patients will be excluded from the study if they meet any of the following criteria: - Previous femoral injury or illness which reduces the function of the extremity - Systemic or chronic injury or illness which reduces the function of the extremity - If the patient is not able to comply with study procedures |
| Country | Name | City | State |
|---|---|---|---|
| Norway | Oslo University Hospital | Oslo |
| Lead Sponsor | Collaborator |
|---|---|
| Oslo University Hospital |
Norway,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Barnhöft | Six questions hip specific questionnaire regarding pain and function. Total score 0 - 100 points. 100 points describes no symptoms. Translated from the english version called The Children's Hospital Oakland Hip Evaluation Scale (CHOHES) - a modification of the Harris Hip Score. | Baseline, 26 week, 52 week follow-up | |
| Primary | Accuracy of the derotation | Accuracy of the derotation measured in degrees on CT comparing the intended/planned correction with the actual derotation | post operative (day1) | |
| Secondary | Knee Injury and Osteoarthritis Outcome Score for Children (KOOS-Child) | 39 items divided in 5 subscales; Pain, other Symptoms (titled as "knee problems"), Difficulty during daily activities (ADL), Function in sport and play (Sport/Play) and Knee related Quality of Life (QOL). The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. | Baseline, 26 week and 52 week follow-up | |
| Secondary | Visual analogue scale | General visual analog scale (VAS) for pain. scale is 0-10, where 10 is maximum pain og 0 is no pain. The scale is a 10 cm long line where the patient sets a mark. The actual level of pain is than measured on the scale from 0-10 (e.g. mark is at 5,5 cm - pain score 5,5) | Baseline, daily first six week. 4 times a day. | |
| Secondary | KIDSCREEN-27 | The KIDSCREEN-27 is a globally used standardized health-related quality of life questionnaire measuring five Rasch scaled dimensions of wellbeing including: (1) Physical Well-being (5 items), (2) Psychological Well-being (7 items), (3) Autonomy and Parents (7 items), (4) Peers and Social Support (4 items), and (5) School Environment (4 items). Responses are indicated using a 5-point ordinal scale with responses ranging from 'never' to 'always', 'not at all' to 'extremely', or 'poor' to 'excellent'. | Baseline, 26 week, 52 week follow-up |